Companies / Santa Cruz Biotechnology / NGFR p75 (ME20.4)
Santa Cruz Biotechnology

NGFR p75 (ME20.4) | Santa Cruz Biotechnology

mouse monoclonal IgG1; NGFR p75 Antibody (ME20.4) is an IgG1 κ mouse monoclonal NGFR p75 antibody that detects NGFR p75 of mouse, rat and human origin by WB, IP, IF and IHC(P). NGFR p75 Antibody (ME20.4) is available as the non-conjugated anti-NGFR p75 antibody form, as well as multiple conjugated forms of anti-NGFR p75 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The Trk oncogene encodes a membrane-spanning protein tyrosine kinase, gp140Trk, whose expression is restricted in vivo to neurons of the sensory spinal and cranial ganglia of neural crest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk A in neural cell lines and in embryonic dorsal root ganglia. Tyrosine phosphorylation of Trk by NGF is rapid, specific and occurs with picomolar quantities of factor, indicating that the response is mediated by physiological amounts of NGF, suggesting that Trk A participates in the primary signal transduction mechanism of NGF. An additional component of the Trk A receptor complex, NGFR p75, binds to the neurotrophic factors with low affinity but is required for efficient signaling. NGFR p75 accelerates Trk A activation and may recruit downstream effector molecules to the liganded complex.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

  • See More